Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
Kristina Tendl-Schulz(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Nicolas Kozakowski(Medical University of Vienna), Katja Pinker(Medical University of Vienna), Christian F. Singer(Comprehensive Cancer Center Vienna), Florian Fitzal, Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Martin Filipits(University of Vienna), Rupert Bartsch(Universitätszahnklinik Wien), Eva-Maria Langthaler(Comprehensive Cancer Center Vienna), Peter Dubsky(Hirslanden Klinik St. Anna), Ulrike Heber(Comprehensive Cancer Center Vienna), Fabian Rössler(Comprehensive Cancer Center Vienna), Martina Mittlböck(Medical University of Vienna), Günther Steger(Barwon Health), Thomas H. Helbich(Vienna General Hospital), Fanny Eckel(Comprehensive Cancer Center Vienna), Philipp Wimmer(Comprehensive Cancer Center Vienna)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
May 7, 2020
Cited by 8
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k